dsm-firmenich has introduced a novel portfolio of taste solutions designed for pharmaceutical formulations.
The new offering was created to address challenges associated with liquid drug product palatability, and encompasses numerous flavours, extracts and aromatic compounds.
It also contains a range of maskers, blockers and sensates, which are suitable for incorporation into solid, liquid or semi-solid dosage forms.
Each product in the range is backed by comprehensive documentation, which can help facilitate the drug approval process for drug developers and manufacturers alike.
Jérôme Barra, Vice President Global Marketing Taste, HNC at dsm-firmenich, comments: “The demand for patient-friendly medications is on the rise, but drug developers face many challenges in masking unpleasant notes and improving the taste of drug products,"
"We’ve unravelled the complex science of designing clean taste profiles to tackle these issues, allowing our customers to focus on effectively bringing their medicines to market.”
“Sitting alongside this new portfolio is the unwavering support dsm-firmenich has become known for," added Fernanda Onofre, Global Marketing Director, Pharma Excipients, HNC at dsm-firmenich.
"We work closely with our customers on all levels — from technical requirements to regulatory obligations — to ensure that they are supported at every stage of the drug development process.”